A trial of a U.K.-developed coronavirus vaccine has found that it is safe and induces an immune reaction, according to preliminary results. Speaking to reporters on Monday, World Health Organization (WHO) emergencies programme executive director Michael Ryan called it “good news” while stating that the initial trial did not appear to have “any serious adverse events.” He added that there is “a long way to go,” but that it is good to see more data “in this very important phase of vaccine discovery.”
Health
Coronavirus: WHO hails ‘good news’ on COVID-19 vaccines, but warns there’s still a long way to go
More Videos
-
Alberta launches organ donation awareness campaign
-
Aamjiwnaang First Nation declares state of emergency over benzene levels
-
Robot assists with direct spine surgery at London, Ont. hospital
-
Breaking down Ontario’s investment into primary health care providers
-
‘I Don’t Know Who You Are’: Canadian film explores HIV health care challenges
-
Health Matters: Breast cancer being found in younger women, study finds
You are viewing an Accelerated Mobile Webpage.
View Original Article